Maternal methamphetamine administration during pregnancy on fetal rat heart development

Hiromasa Inoue, Masato Nakatome, Masaru Terada, Mizuki Mizuno, Reiko Ono, Morio Iino, Yukiko Ino, Yoshiaki Ogura, Hisanaga Kuroki, Ryoji Matoba

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Methamphetamine (MAP) is one of the most abused drugs in Japan. The rate of MAP abuse by young women has recently reached more than 50 percent in adolescents. A major health concern is that these women will continue to use MAP during pregnancy. The purpose of this study was to investigate whether MAP administered to the mother during pregnancy would change the expression of α- and β- myosin heavy chain (MHC) mRNA in rat neonatal hearts, as detected by quantitative RT-PCR. In addition, morphological changes in the rat neonatal ventricles were examined. Pregnant rats were injected intraperitoneally with MAP (1 mg/kg/day) starting at day 0 of gestation and ending at day 21. There was a significant increase in α-MHC mRNA expression in the neonatal ventricular muscle in the experimental group compared with the control at postnatal day (P) 0 and 5. α-MHC mRNA expression in both groups was similar after P9. β-MHC mRNA expression was similar in both groups at P0. Postnatal β-MHC mRNA expression decreased rapidly, but significant alteration was not detected. Neonatal rats at P0 exhibited some cardiac changes, including hypertrophy, degeneration, and disarrangement of myofibers, but these lesions disappeared by P14. We conclude that chronic maternal administration of MAP changes the α- and β-MHC mRNA expression pattern in fetal and neonatal hearts, correlating with abnormal development, plasma level of hormones, and myocardial damage. At the same time, it is indicated that neonatal cardiomyocytes have reversibility.

Original languageEnglish
Pages (from-to)1529-1540
Number of pages12
JournalLife Sciences
Volume74
Issue number12
DOIs
Publication statusPublished - 2004 Feb 6
Externally publishedYes

Fingerprint

Fetal Heart
Methamphetamine
Myosin Heavy Chains
Rats
Mothers
Pregnancy
Messenger RNA
Cardiac Myocytes
Hypertrophy
Muscle
Japan
Health
Hormones
Plasmas
Muscles
Polymerase Chain Reaction
Pharmaceutical Preparations

Keywords

  • α-MHC
  • β-MHC
  • Fetal heart
  • Hormone
  • Methamphetamine
  • mRNA
  • Pregnancy
  • Quantitative RT-PCR

ASJC Scopus subject areas

  • Pharmacology

Cite this

Inoue, H., Nakatome, M., Terada, M., Mizuno, M., Ono, R., Iino, M., ... Matoba, R. (2004). Maternal methamphetamine administration during pregnancy on fetal rat heart development. Life Sciences, 74(12), 1529-1540. https://doi.org/10.1016/j.lfs.2003.08.016

Maternal methamphetamine administration during pregnancy on fetal rat heart development. / Inoue, Hiromasa; Nakatome, Masato; Terada, Masaru; Mizuno, Mizuki; Ono, Reiko; Iino, Morio; Ino, Yukiko; Ogura, Yoshiaki; Kuroki, Hisanaga; Matoba, Ryoji.

In: Life Sciences, Vol. 74, No. 12, 06.02.2004, p. 1529-1540.

Research output: Contribution to journalArticle

Inoue, H, Nakatome, M, Terada, M, Mizuno, M, Ono, R, Iino, M, Ino, Y, Ogura, Y, Kuroki, H & Matoba, R 2004, 'Maternal methamphetamine administration during pregnancy on fetal rat heart development', Life Sciences, vol. 74, no. 12, pp. 1529-1540. https://doi.org/10.1016/j.lfs.2003.08.016
Inoue H, Nakatome M, Terada M, Mizuno M, Ono R, Iino M et al. Maternal methamphetamine administration during pregnancy on fetal rat heart development. Life Sciences. 2004 Feb 6;74(12):1529-1540. https://doi.org/10.1016/j.lfs.2003.08.016
Inoue, Hiromasa ; Nakatome, Masato ; Terada, Masaru ; Mizuno, Mizuki ; Ono, Reiko ; Iino, Morio ; Ino, Yukiko ; Ogura, Yoshiaki ; Kuroki, Hisanaga ; Matoba, Ryoji. / Maternal methamphetamine administration during pregnancy on fetal rat heart development. In: Life Sciences. 2004 ; Vol. 74, No. 12. pp. 1529-1540.
@article{3f2856cd720f4ea3bbbbe73d33a66c08,
title = "Maternal methamphetamine administration during pregnancy on fetal rat heart development",
abstract = "Methamphetamine (MAP) is one of the most abused drugs in Japan. The rate of MAP abuse by young women has recently reached more than 50 percent in adolescents. A major health concern is that these women will continue to use MAP during pregnancy. The purpose of this study was to investigate whether MAP administered to the mother during pregnancy would change the expression of α- and β- myosin heavy chain (MHC) mRNA in rat neonatal hearts, as detected by quantitative RT-PCR. In addition, morphological changes in the rat neonatal ventricles were examined. Pregnant rats were injected intraperitoneally with MAP (1 mg/kg/day) starting at day 0 of gestation and ending at day 21. There was a significant increase in α-MHC mRNA expression in the neonatal ventricular muscle in the experimental group compared with the control at postnatal day (P) 0 and 5. α-MHC mRNA expression in both groups was similar after P9. β-MHC mRNA expression was similar in both groups at P0. Postnatal β-MHC mRNA expression decreased rapidly, but significant alteration was not detected. Neonatal rats at P0 exhibited some cardiac changes, including hypertrophy, degeneration, and disarrangement of myofibers, but these lesions disappeared by P14. We conclude that chronic maternal administration of MAP changes the α- and β-MHC mRNA expression pattern in fetal and neonatal hearts, correlating with abnormal development, plasma level of hormones, and myocardial damage. At the same time, it is indicated that neonatal cardiomyocytes have reversibility.",
keywords = "α-MHC, β-MHC, Fetal heart, Hormone, Methamphetamine, mRNA, Pregnancy, Quantitative RT-PCR",
author = "Hiromasa Inoue and Masato Nakatome and Masaru Terada and Mizuki Mizuno and Reiko Ono and Morio Iino and Yukiko Ino and Yoshiaki Ogura and Hisanaga Kuroki and Ryoji Matoba",
year = "2004",
month = "2",
day = "6",
doi = "10.1016/j.lfs.2003.08.016",
language = "English",
volume = "74",
pages = "1529--1540",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "12",

}

TY - JOUR

T1 - Maternal methamphetamine administration during pregnancy on fetal rat heart development

AU - Inoue, Hiromasa

AU - Nakatome, Masato

AU - Terada, Masaru

AU - Mizuno, Mizuki

AU - Ono, Reiko

AU - Iino, Morio

AU - Ino, Yukiko

AU - Ogura, Yoshiaki

AU - Kuroki, Hisanaga

AU - Matoba, Ryoji

PY - 2004/2/6

Y1 - 2004/2/6

N2 - Methamphetamine (MAP) is one of the most abused drugs in Japan. The rate of MAP abuse by young women has recently reached more than 50 percent in adolescents. A major health concern is that these women will continue to use MAP during pregnancy. The purpose of this study was to investigate whether MAP administered to the mother during pregnancy would change the expression of α- and β- myosin heavy chain (MHC) mRNA in rat neonatal hearts, as detected by quantitative RT-PCR. In addition, morphological changes in the rat neonatal ventricles were examined. Pregnant rats were injected intraperitoneally with MAP (1 mg/kg/day) starting at day 0 of gestation and ending at day 21. There was a significant increase in α-MHC mRNA expression in the neonatal ventricular muscle in the experimental group compared with the control at postnatal day (P) 0 and 5. α-MHC mRNA expression in both groups was similar after P9. β-MHC mRNA expression was similar in both groups at P0. Postnatal β-MHC mRNA expression decreased rapidly, but significant alteration was not detected. Neonatal rats at P0 exhibited some cardiac changes, including hypertrophy, degeneration, and disarrangement of myofibers, but these lesions disappeared by P14. We conclude that chronic maternal administration of MAP changes the α- and β-MHC mRNA expression pattern in fetal and neonatal hearts, correlating with abnormal development, plasma level of hormones, and myocardial damage. At the same time, it is indicated that neonatal cardiomyocytes have reversibility.

AB - Methamphetamine (MAP) is one of the most abused drugs in Japan. The rate of MAP abuse by young women has recently reached more than 50 percent in adolescents. A major health concern is that these women will continue to use MAP during pregnancy. The purpose of this study was to investigate whether MAP administered to the mother during pregnancy would change the expression of α- and β- myosin heavy chain (MHC) mRNA in rat neonatal hearts, as detected by quantitative RT-PCR. In addition, morphological changes in the rat neonatal ventricles were examined. Pregnant rats were injected intraperitoneally with MAP (1 mg/kg/day) starting at day 0 of gestation and ending at day 21. There was a significant increase in α-MHC mRNA expression in the neonatal ventricular muscle in the experimental group compared with the control at postnatal day (P) 0 and 5. α-MHC mRNA expression in both groups was similar after P9. β-MHC mRNA expression was similar in both groups at P0. Postnatal β-MHC mRNA expression decreased rapidly, but significant alteration was not detected. Neonatal rats at P0 exhibited some cardiac changes, including hypertrophy, degeneration, and disarrangement of myofibers, but these lesions disappeared by P14. We conclude that chronic maternal administration of MAP changes the α- and β-MHC mRNA expression pattern in fetal and neonatal hearts, correlating with abnormal development, plasma level of hormones, and myocardial damage. At the same time, it is indicated that neonatal cardiomyocytes have reversibility.

KW - α-MHC

KW - β-MHC

KW - Fetal heart

KW - Hormone

KW - Methamphetamine

KW - mRNA

KW - Pregnancy

KW - Quantitative RT-PCR

UR - http://www.scopus.com/inward/record.url?scp=9144256856&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9144256856&partnerID=8YFLogxK

U2 - 10.1016/j.lfs.2003.08.016

DO - 10.1016/j.lfs.2003.08.016

M3 - Article

VL - 74

SP - 1529

EP - 1540

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 12

ER -